WO2011022679A3 - Composés cannabinoïdes benzofurane et méthodes d'utilisation associées - Google Patents
Composés cannabinoïdes benzofurane et méthodes d'utilisation associées Download PDFInfo
- Publication number
- WO2011022679A3 WO2011022679A3 PCT/US2010/046208 US2010046208W WO2011022679A3 WO 2011022679 A3 WO2011022679 A3 WO 2011022679A3 US 2010046208 W US2010046208 W US 2010046208W WO 2011022679 A3 WO2011022679 A3 WO 2011022679A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- benzofuran
- related methods
- cannabinoid compounds
- compounds
- receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention a pour objet des composés analogues de cannabinoïdes furanopyridine de la formule I. Les composés sont utiles pour modifier l'activité des récepteurs CB1 et CB2 et traiter des affections médiées par ces récepteurs.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23550409P | 2009-08-20 | 2009-08-20 | |
US61/235,504 | 2009-08-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011022679A2 WO2011022679A2 (fr) | 2011-02-24 |
WO2011022679A3 true WO2011022679A3 (fr) | 2011-06-16 |
Family
ID=43605843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/046208 WO2011022679A2 (fr) | 2009-08-20 | 2010-08-20 | Composés cannabinoïdes benzofurane et méthodes dutilisation associées |
Country Status (2)
Country | Link |
---|---|
US (1) | US8476309B2 (fr) |
WO (1) | WO2011022679A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103242273B (zh) | 2012-02-09 | 2015-06-03 | 中国科学院上海药物研究所 | 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途 |
US10897925B2 (en) | 2018-07-27 | 2021-01-26 | Joseph Pandolfino | Articles and formulations for smoking products and vaporizers |
US20200035118A1 (en) | 2018-07-27 | 2020-01-30 | Joseph Pandolfino | Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01199957A (ja) * | 1988-02-04 | 1989-08-11 | Mitsui Petrochem Ind Ltd | ベンゾフラン誘導体、クロメン誘導体および医薬 |
US5087638A (en) * | 1984-06-20 | 1992-02-11 | Merck Frosst Canada, Inc. | Benzofuran derivatives |
WO2006129318A2 (fr) * | 2005-05-31 | 2006-12-07 | Pharmos Corporation | Derives de benzofuranne presentant des activites therapeutiques |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2909754A1 (de) * | 1979-03-13 | 1980-09-18 | Thomae Gmbh Dr K | Neue benzofuran- und benzothiophenderivate, deren herstellung und deren verwendung als arzneimittel |
CA1281325C (fr) * | 1984-06-20 | 1991-03-12 | Patrice C. Belanger | Derives de benzofurane |
DK1188747T3 (da) * | 1999-05-24 | 2006-01-23 | Mitsubishi Pharma Corp | Phenoxypropylaminforbindelser |
-
2010
- 2010-08-20 US US12/860,633 patent/US8476309B2/en not_active Expired - Fee Related
- 2010-08-20 WO PCT/US2010/046208 patent/WO2011022679A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087638A (en) * | 1984-06-20 | 1992-02-11 | Merck Frosst Canada, Inc. | Benzofuran derivatives |
JPH01199957A (ja) * | 1988-02-04 | 1989-08-11 | Mitsui Petrochem Ind Ltd | ベンゾフラン誘導体、クロメン誘導体および医薬 |
WO2006129318A2 (fr) * | 2005-05-31 | 2006-12-07 | Pharmos Corporation | Derives de benzofuranne presentant des activites therapeutiques |
Also Published As
Publication number | Publication date |
---|---|
WO2011022679A2 (fr) | 2011-02-24 |
US8476309B2 (en) | 2013-07-02 |
US20110046175A1 (en) | 2011-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ603151A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives | |
MY156530A (en) | Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators | |
WO2011069063A3 (fr) | Composés multicycliques et leurs procédés d'utilisation | |
IN2012DN00692A (fr) | ||
MX2012001618A (es) | Derivados de 5-fluoropirimidinona. | |
SMT201200017B (it) | Nuovi antagonisti P2X7R e il loro uso. | |
TN2012000578A1 (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
WO2011006886A3 (fr) | Composés azole portant un substituant soufré xiv | |
UA109547C2 (uk) | Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин | |
WO2011083150A3 (fr) | Petites molécules pour traiter l'obésité | |
MX2011009369A (es) | 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
WO2011022692A3 (fr) | Composés de cannabinoïde furanopyridine et procédés d'utilisation afférents | |
ZA201006782B (en) | Novel p2x7r antagonists and thier use | |
WO2010127152A3 (fr) | Composés et compositions comme inhibiteurs de la prostaglandine e synthase-1 microsomale | |
EP2685828A4 (fr) | Dérivés de 3-azabicyclo[3.1.0]hexane substitués utiles en tant qu'antagonistes de ccr2 | |
WO2010102778A3 (fr) | 3-aminoisoxazolopyridines substituées en tant que modulateurs de kcnq 2/3 | |
IN2012DN00695A (fr) | ||
UA107671C2 (en) | N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives | |
IN2012DN00539A (fr) | ||
WO2009120192A3 (fr) | Procédé pour la préparation de dérivés d’hétéroaryle benzo-condensés | |
AU2012357747A8 (en) | TRPM8 antagonists | |
MX2011008662A (es) | 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3. | |
MX2011009338A (es) | 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3. | |
WO2011073370A3 (fr) | Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée | |
WO2011022679A3 (fr) | Composés cannabinoïdes benzofurane et méthodes d'utilisation associées |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10810682 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10810682 Country of ref document: EP Kind code of ref document: A2 |